STOCKHOLDERS' EQUITY (Details 3) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Number Options
Options outstanding, ending
Stock Options
Number Options
Options outstanding, beginning	13,733,488	10,590,161
Options Granted	2,583,677	5,121,250	10,682,218	[1]
Options Exercised	(75,423)	(1,931,788)	(92,057)
Options Expired	(250)
Options Cancelled	(608,750)	(46,135)
Options outstanding, ending	15,632,742	13,733,488	10,590,161
Vested and exercisable	11,282,627
Weighted Average Exercise Price
Options outstanding, beginning	$ 1.16	$ 0.16
Granted	$ 3.31	$ 2.8	$ 0.16	[1]
Exercised		$ 0.13	$ 0.19
Options outstanding, ending	$ 1.44	$ 1.16	$ 0.16
Vested and exercisable	$ 0.8
Weighted Average Remaining Contractual Life
Options outstanding, beginning	7 years 8 months 12 days	7 years 7 months 6 days
Granted	9 years 9 months 18 days	9 years 8 months 12 days	7 years 7 months 6 days	[1]
Options outstanding, ending	7 years 2 months 12 days	7 years 8 months 12 days	7 years 7 months 6 days
Vested and exercisable	6 years 6 months
Aggregate Intrinsic Value
Options outstanding, beginning	$ 26,804,117	$ 14,067,649
Granted	$ 4,920,981	$ 1,737,530	$ 14,188,484	[1]
Options outstanding, ending	58,878,132	26,804,117	14,067,649
Vested and exercisable	$ 48,321,930

[1] This includes (i) VitaMed Options granted between October 2008 and December 31, 2010 for an aggregate of 7,639,722 Units, of which 16,000 were canceled prior to conversion (or Options for 9,357,561 shares per the Conversion Ratio), (ii) VitaMed Options granted between January 1, 2011 and October 3, 2011 for an aggregate of 621,000 Units (or Options for 762,235 shares per the Conversion Ratio) and (iii) Options granted between October 4, 2011 and December 31, 2011 for an aggregate of 562,422 shares. The terms and conditions of the VitaMed Options were reflected in the replacement Options including the number of shares vested.